helicobacter-pylori

Documents about helicobacter-pylori

• H-pylori_dFliM_GC#349849CaltechDATA
• H_pylori_dFliO_GC#349856CaltechDATA
• miRNA in Pediatric Gastritis#892119ClinicalTrials.gov
• H. pylori 26695 / Hs.746T#1029433CaltechDATA
• H.pylori 26695 delta-cagH#1044095CaltechDATA
• H.pylori with treatment A#1056803CaltechDATA
• Specimen Collection Study for H. Pylori Testing#852475ClinicalTrials.gov
• Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study#208471ClinicalTrials.gov
• Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection#366625ClinicalTrials.gov
• Helicobacter pylori lipopolysaccharide in the IL-2 milieu activates lymphocytes from dyspeptic children#418136Lund University Publications
• Helicobacter pylori cagA + is associated with milder duodenal histological changes in chilean celiac patients#646919Repositorio Académico de la Universidad de Chile
• Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment#911148ClinicalTrials.gov
• Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study#217073ClinicalTrials.gov
• Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients#154705ClinicalTrials.gov
• H. pylori 26695 WT / AGS#640325CaltechDATA
• Prevalence and associated factors of Helicobacter pylori seropositivity, including mode of delivery, among asymptomatic adolescents in Central Sudan: a community-based cross-sectional study.#473146PubMed
• Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment#899180ClinicalTrials.gov
• Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study#234459ClinicalTrials.gov
• Internalization of <i>Helicobacter pylori</i> into gastric epithelial cells: mechanisms and intervention strategies#253505Europe PMC
• An investigation of helicobacter pylori integrative and conjugative elements#470590University of Nottingham Repository
• Prevalence of primary <i>Helicobacter pylori</i> antibiotic resistance in Europe over the past four decades#642660Europe PMC
• Recurrencia de la infección gástrica con Helicobacter pylori en adultos peruanos con distrés postprandial dos años después de la erradicación exitosa#666874Repositorio Universidad Peruana Cayetano Heredia
• Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine#837636ClinicalTrials.gov
• Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori#912518ClinicalTrials.gov
• Clarithromycin Resistant Tailored Therapy#201799ClinicalTrials.gov
• A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide#181802ClinicalTrials.gov
• Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)#256913ClinicalTrials.gov
• Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study#471479ClinicalTrials.gov
• Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori#885903ClinicalTrials.gov
• Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen#892884ClinicalTrials.gov
• Effect of Simethicone on Helicobacter Pylori Detection in Routine Endoscopy#914619ClinicalTrials.gov
• H. pylori 26695 / 20 nm gold-DNA#1056805CaltechDATA
• H. pylori 26695 / 20 nm gold-DNA#1056844CaltechDATA
• Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection#123493ClinicalTrials.gov
• Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy#979969ClinicalTrials.gov
• Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole#982263ClinicalTrials.gov
• Validación del test rápido de la ureasa para la detección del Helicobacter pylori en el Hospital Nacional Cayetano Heredia, Lima, Perú Validation of the rapid urease test for the detection of Helicobacter#263623Repositorio Universidad Peruana Cayetano Heredia
• Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality#863880ClinicalTrials.gov
• Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation#852261ClinicalTrials.gov
• Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2#829079ClinicalTrials.gov
• Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial#279546ClinicalTrials.gov
• Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy#441951ClinicalTrials.gov
• A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection#895333ClinicalTrials.gov
• A Multi-center Study for Eradication of Refractory Helicobacter Pylori#349984ClinicalTrials.gov
• Tetracycline Versus Doxycycline for HP Rescue Therapy#474794ClinicalTrials.gov
• TAK-438 Bismuth Drug Interaction Study#873776ClinicalTrials.gov
• <i>Helicobacter pylori</i> in oral and gastric pathologies: a narrative review of potential bidirectional pathogenic interactions#478500Europe PMC
• Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease#840179ClinicalTrials.gov
• New Strategy for the Detection and Treatment of Helicobacter Pylori Infections in Primary Care Guided by a Non-invasive PCR in Stool#873005ClinicalTrials.gov
• Potential pathogenesis of <i>Helicobacter pylori</i> strains from Cameroon: seroprevalence of 10 proteins involved in the pathogenesis of <i>Helicobacter pylori</i>-related gastro-duodenal diseases, measured using a new multiplex immunoassay among <i>Helicobacter pylori</i> IgM-positive dyspeptic patients#123345Europe PMC